Target intelligence / Profile preview

Novel transcript, antisense to NR4A2 (ENSG00000309294)

Target: ENSG00000309294
Molecular classification: Other (antisense non-coding RNA)

Overview

ENSG00000309294 is a novel non-coding RNA transcript annotated as antisense to NR4A2, the gene encoding the nuclear receptor subfamily 4 group A member 2 (NURR1). There is no evidence this antisense transcript encodes a protein or acts as a direct therapeutic target. No experimentally confirmed function, disease association, or druggability has been reported in current databases. In gene catalogs and functional databases, it is only listed as an RNA gene, and its biological role (if any) is speculative at this stage.

Other names: antisense to NR4A2ENSG00000309294

Mechanism of action

None known

Biological functions

Unknown; generally, antisense RNAs may regulate their sense counterpart gene's expression post-transcriptionally, but specific functions for this transcript are not elucidated

Beyond the preview

Go deeper on Novel transcript, antisense to NR4A2 (ENSG00000309294).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to NR4A2 (ENSG00000309294).

Explore the full profile